Nippon India Pharma Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹217 Cr | ₹8161 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.35 | 1.82 |
Manager | Rohan Korde | Sailesh Raj Bhan |
ISIN Code | INF00XX01BL5 | INF204K01968 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -3.85% | -2.32% |
6 Month | -12.09% | -11.01% |
1 Year | 11.23% | 8.24% |
3 Year | 16.93% | 17.42% |
5 Year | - | 24.86% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | -10.76% | -8.53% |
1 Year | -8.67% | -7.01% |
3 Year | 19.12% | 20.46% |
5 Year | - | 17.84% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 24.79% | 18.19% |
3 Year | 19.26% | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 15.667% | 15.623% |
Sharp | 0.739% | 0.707% |
Beta | 0.959% | 0.908% |
Alpha | -1.413% | 0.486% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Rohan Korde | Sailesh Raj Bhan |
Total AUM | ₹4626 Cr | ₹96086 Cr |
Fund Manage | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 7.56529 | 1.36231 |
Mid Cap | 31.21636 | 32.7767 |
Small Cap | 32.03192 | 27.13989 |
Large Cap | 29.18645 | 38.72112 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 8.42409 | 1.36231 |
Healthcare | 88.75669 | 98.63771 |
Basic Materials | 2.07702 | - |
Industrials | 0.74222 | - |
Financial Services | 0 | - |
Top Comparisons
ICICI Prudential Gilt Fund - Growth
3Y Returns7.47%
Invesco India GILT Fund - Growth
3Y Returns6.84%
Nippon India Nifty 50 Value 20 Index Fund - Regular Plan - Growth Option
3Y Returns12.11%
UTI Nifty 200 Momentum 30 Index Fund - Regular Plan - Growth Option
3Y Returns11.89%
ICICI Prudential Nifty Next 50 Index Fund - Growth
3Y Returns13.84%
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - Growth
3Y Returns14.49%
ICICI Prudential Manufacturing Fund - Growth Option
3Y Returns21.61%
Kotak Pioneer Fund- Regular Plan- Growth Option
3Y Returns16.31%